Flurbiprofen: Difference between revisions
No edit summary |
consistent citation formatting; templated cites |
||
Line 54: | Line 54: | ||
}} |
}} |
||
'''Flurbiprofen''' is a member of the [[phenylalkanoic acid]] derivative family of [[nonsteroidal anti-inflammatory drug]]s (NSAIDs). It is primarily indicated as a pre-operative [[miosis|anti-miotic]] (in an [[eye drop|ophthalmic solution]]) as well as orally for [[arthritis]] or dental pain. Side effects are analogous to those of ibuprofen.<ref>{{cite web|title=Lexicomp: Flurbiprofen|url=http://online.lexi.com/lco/action/doc/retrieve/docid/patch_f/1797302|website=Lexicomp|publisher=Wolters Kluwer| |
'''Flurbiprofen''' is a member of the [[phenylalkanoic acid]] derivative family of [[nonsteroidal anti-inflammatory drug]]s (NSAIDs). It is primarily indicated as a pre-operative [[miosis|anti-miotic]] (in an [[eye drop|ophthalmic solution]]) as well as orally for [[arthritis]] or dental pain. Side effects are analogous to those of ibuprofen.<ref>{{cite web|title=Lexicomp: Flurbiprofen|url=http://online.lexi.com/lco/action/doc/retrieve/docid/patch_f/1797302|website=Lexicomp|publisher=Wolters Kluwer|access-date=25 September 2015}}</ref> |
||
It was derived from [[propionic acid]] by the research arm of [[Boots UK]] during the 1960s, a period which also included the discovery of [[ibuprofen]], [[indometacin]], [[diclofenac]], [[naproxen]], [[ketoprofen]], and [[sulindac]].<ref name = plat12>{{cite journal| |
It was derived from [[propionic acid]] by the research arm of [[Boots UK]] during the 1960s, a period which also included the discovery of [[ibuprofen]], [[indometacin]], [[diclofenac]], [[naproxen]], [[ketoprofen]], and [[sulindac]].<ref name = plat12>{{cite journal | vauthors = Rainsford KD | title = Fifty years since the discovery of ibuprofen | journal = Inflammopharmacology | volume = 19 | issue = 6 | pages = 293–7 | date = December 2011 | pmid = 22120888 | doi = 10.1007/s10787-011-0103-7 }}</ref><ref>{{cite book | first1 = Janos | last1 = Fischer | first2 = C. Robin | last2 = Ganellin | name-list-format = vanc | title = Analogue-based Drug Discovery II. | publisher = John Wiley & Sons | date = 2010 | isbn = 9783527632121 }}</ref>{{rp|34}} |
||
<!-- Society and culture --> |
<!-- Society and culture --> |
||
It was patented in 1964 by [[Boots UK]] and approved for medical use in 1987.<ref name=Fis2006>{{cite book |last1=Fischer |first1=Jnos |last2=Ganellin |first2=C. Robin |title=Analogue-based Drug Discovery |date=2006 |publisher=John Wiley & Sons |isbn=9783527607495 |page=520 |url=https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA520 |language=en}}</ref> It was approved in the US in 1988; the first [[generic drug|generic]] was approved in 1994.<ref>{{cite book|title=Approved Drug Products with Therapeutic Equivalence Evaluations|date=2014|publisher=FDA|edition=36th|url=http://www.nber.org/fda/orange-book/pdf/UCM071436.pdf}}</ref>{{rp|158}} |
It was patented in 1964 by [[Boots UK]] and approved for medical use in 1987.<ref name=Fis2006>{{cite book |last1=Fischer |first1=Jnos |last2=Ganellin |first2=C. Robin | name-list-format = vanc |title=Analogue-based Drug Discovery |date=2006 |publisher=John Wiley & Sons |isbn=9783527607495 |page=520 |url=https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA520 |language=en}}</ref> It was approved in the US in 1988; the first [[generic drug|generic]] was approved in 1994.<ref>{{cite book|title=Approved Drug Products with Therapeutic Equivalence Evaluations|date=2014|publisher=FDA|edition=36th|url=http://www.nber.org/fda/orange-book/pdf/UCM071436.pdf}}</ref>{{rp|158}} |
||
==Society and culture== |
==Society and culture== |
||
===Brand names=== |
===Brand names=== |
||
As of 2016 the drug was available worldwide as drops for ophthalmic use and as tablets, both in various strengths, under many brand names which include:Acustop Cataplasma, Adofeed, Anazin, Anflupin, Anorcid, Ansaid, Antadys, Antafen, Antipain, Baenazin, Benactiv, Biprofin, Biprotec, Bro-Z, Brufen, Brufoz, Cebutid, Clinadol, Coryfin, Dispain, Edolfene, Eyeflur, Falken, Fiera, Flu Ro Fen, Flubifix, Flufen, Flugalin, Flupe, Flur di fen, Fluractive, Fluran, Flurbi Pap, Flurbic, Flurbiprofen, Flurbiprofène, Flurbiprofeno, Flurflex, Flurofen, Fluroptic, Fo Bi Pu Luo Fun, Forphen, Fortine, Froben, Frolix, Fubifen, Fubiprofen, Fubofen, Fukon, Fulruban, Furofen, Kai Fen, Kavoflog, Kotton, Lefenine, Majezik, Maprofen, Maxaljin, Maximus, Meiprofen, Neliacan, Nibelon, Nirolex Gola, Ocufen, Ocuflur, Optifen, Orofaringeo, Painil, Profen, Projezik, Ropion, Sigmaprofen, Stayban, Strefen, Strepfen, Strepflam, Strepsils (various formulations), Sulan, Tie Shr Shu, TransAct, Upnon, Urbifen, Yakuban, Zepolas, Zeralgo, Zero-P, and Zeton.<ref>{{cite web|title=Flurbiprofen - International Brand Names|url=https://www.drugs.com/international/flurbiprofen.html|publisher=Drugs.com| |
As of 2016 the drug was available worldwide as drops for ophthalmic use and as tablets, both in various strengths, under many brand names which include:Acustop Cataplasma, Adofeed, Anazin, Anflupin, Anorcid, Ansaid, Antadys, Antafen, Antipain, Baenazin, Benactiv, Biprofin, Biprotec, Bro-Z, Brufen, Brufoz, Cebutid, Clinadol, Coryfin, Dispain, Edolfene, Eyeflur, Falken, Fiera, Flu Ro Fen, Flubifix, Flufen, Flugalin, Flupe, Flur di fen, Fluractive, Fluran, Flurbi Pap, Flurbic, Flurbiprofen, Flurbiprofène, Flurbiprofeno, Flurflex, Flurofen, Fluroptic, Fo Bi Pu Luo Fun, Forphen, Fortine, Froben, Frolix, Fubifen, Fubiprofen, Fubofen, Fukon, Fulruban, Furofen, Kai Fen, Kavoflog, Kotton, Lefenine, Majezik, Maprofen, Maxaljin, Maximus, Meiprofen, Neliacan, Nibelon, Nirolex Gola, Ocufen, Ocuflur, Optifen, Orofaringeo, Painil, Profen, Projezik, Ropion, Sigmaprofen, Stayban, Strefen, Strepfen, Strepflam, Strepsils (various formulations), Sulan, Tie Shr Shu, TransAct, Upnon, Urbifen, Yakuban, Zepolas, Zeralgo, Zero-P, and Zeton.<ref>{{cite web|title=Flurbiprofen - International Brand Names|url=https://www.drugs.com/international/flurbiprofen.html|publisher=Drugs.com|access-date=14 November 2016}}</ref> |
||
===Cost=== |
===Cost=== |
||
As of 2015 the cost for a typical month of medication in the United States is 50 to US$100.<ref name=Ric2015>{{cite book|last1=Hamilton|first1=Richart|title=Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition|date=2015|publisher=Jones & Bartlett Learning|isbn=9781284057560|page=8}}</ref> |
As of 2015 the cost for a typical month of medication in the United States is 50 to US$100.<ref name=Ric2015>{{cite book|last1=Hamilton|first1=Richart | name-list-format = vanc |title=Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition|date=2015|publisher=Jones & Bartlett Learning|isbn=9781284057560|page=8}}</ref> |
||
==See also== |
== See also == |
||
*[[Flurizan]] |
*[[Flurizan]] |
||
==References== |
== References == |
||
{{reflist}} |
{{reflist}} |
||
==Further reading== |
== Further reading == |
||
U.S. National Center for Biotechnology Information: [https://www.ncbi.nlm.nih.gov/books/NBK537365/ Medical Genetics Summaries - Flurbiprofen Therapy and CYP2C9 Genotype] |
U.S. National Center for Biotechnology Information: [https://www.ncbi.nlm.nih.gov/books/NBK537365/ Medical Genetics Summaries - Flurbiprofen Therapy and CYP2C9 Genotype] |
||
Line 88: | Line 88: | ||
[[Category:Phenyl alkanoic acids]] |
[[Category:Phenyl alkanoic acids]] |
||
[[Category:Propionic acids]] |
[[Category:Propionic acids]] |
||
{{respiratory-system-drug-stub}} |
{{respiratory-system-drug-stub}} |
Revision as of 04:51, 19 September 2019
Clinical data | |
---|---|
Trade names | Ansaid, Ocufen, Strepfen |
Other names | (±)-2-fluoro-α-methyl-(1,1'-biphenyl)-4-acetic acid |
AHFS/Drugs.com | Monograph |
MedlinePlus | a687005 |
Pregnancy category |
|
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Protein binding | > 99% |
Metabolism | Hepatic (CYP2C9) |
Elimination half-life | 4.7-5.7 hours |
Excretion | Renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
PDB ligand | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.023.479 |
Chemical and physical data | |
Formula | C15H13FO2 |
Molar mass | 244.261 g/mol g·mol−1 |
3D model (JSmol) | |
Chirality | Racemic mixture |
Melting point | 117 °C (243 °F) |
| |
| |
(verify) |
Flurbiprofen is a member of the phenylalkanoic acid derivative family of nonsteroidal anti-inflammatory drugs (NSAIDs). It is primarily indicated as a pre-operative anti-miotic (in an ophthalmic solution) as well as orally for arthritis or dental pain. Side effects are analogous to those of ibuprofen.[2]
It was derived from propionic acid by the research arm of Boots UK during the 1960s, a period which also included the discovery of ibuprofen, indometacin, diclofenac, naproxen, ketoprofen, and sulindac.[3][4]: 34
It was patented in 1964 by Boots UK and approved for medical use in 1987.[5] It was approved in the US in 1988; the first generic was approved in 1994.[6]: 158
Society and culture
Brand names
As of 2016 the drug was available worldwide as drops for ophthalmic use and as tablets, both in various strengths, under many brand names which include:Acustop Cataplasma, Adofeed, Anazin, Anflupin, Anorcid, Ansaid, Antadys, Antafen, Antipain, Baenazin, Benactiv, Biprofin, Biprotec, Bro-Z, Brufen, Brufoz, Cebutid, Clinadol, Coryfin, Dispain, Edolfene, Eyeflur, Falken, Fiera, Flu Ro Fen, Flubifix, Flufen, Flugalin, Flupe, Flur di fen, Fluractive, Fluran, Flurbi Pap, Flurbic, Flurbiprofen, Flurbiprofène, Flurbiprofeno, Flurflex, Flurofen, Fluroptic, Fo Bi Pu Luo Fun, Forphen, Fortine, Froben, Frolix, Fubifen, Fubiprofen, Fubofen, Fukon, Fulruban, Furofen, Kai Fen, Kavoflog, Kotton, Lefenine, Majezik, Maprofen, Maxaljin, Maximus, Meiprofen, Neliacan, Nibelon, Nirolex Gola, Ocufen, Ocuflur, Optifen, Orofaringeo, Painil, Profen, Projezik, Ropion, Sigmaprofen, Stayban, Strefen, Strepfen, Strepflam, Strepsils (various formulations), Sulan, Tie Shr Shu, TransAct, Upnon, Urbifen, Yakuban, Zepolas, Zeralgo, Zero-P, and Zeton.[7]
Cost
As of 2015 the cost for a typical month of medication in the United States is 50 to US$100.[8]
See also
References
- ^ "FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 Oct 2023.
- ^ "Lexicomp: Flurbiprofen". Lexicomp. Wolters Kluwer. Retrieved 25 September 2015.
- ^ Rainsford KD (December 2011). "Fifty years since the discovery of ibuprofen". Inflammopharmacology. 19 (6): 293–7. doi:10.1007/s10787-011-0103-7. PMID 22120888.
- ^ Fischer, Janos; Ganellin, C. Robin (2010). Analogue-based Drug Discovery II. John Wiley & Sons. ISBN 9783527632121.
{{cite book}}
: Unknown parameter|name-list-format=
ignored (|name-list-style=
suggested) (help) - ^ Fischer, Jnos; Ganellin, C. Robin (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 520. ISBN 9783527607495.
{{cite book}}
: Unknown parameter|name-list-format=
ignored (|name-list-style=
suggested) (help) - ^ Approved Drug Products with Therapeutic Equivalence Evaluations (PDF) (36th ed.). FDA. 2014.
- ^ "Flurbiprofen - International Brand Names". Drugs.com. Retrieved 14 November 2016.
- ^ Hamilton, Richart (2015). Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition. Jones & Bartlett Learning. p. 8. ISBN 9781284057560.
{{cite book}}
: Unknown parameter|name-list-format=
ignored (|name-list-style=
suggested) (help)
Further reading
U.S. National Center for Biotechnology Information: Medical Genetics Summaries - Flurbiprofen Therapy and CYP2C9 Genotype